Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
This study has been completed.
Sponsor:
The Alfred
Collaborator:
Cellestis
Information provided by (Responsible Party):
Jennifer Hoy, The Alfred
ClinicalTrials.gov Identifier:
NCT00168259
First received: September 13, 2005
Last updated: January 19, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130312224816im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
The study is designed to evaluate interferon responses to CMV in HIV positive individuals and a component will look at interferon responses to CMV in HIV positive individuals over time after commencement of antiretroviral therapy. We will also look at the correlation between CD4 T cell numbers and HLA type with the interferon response.
Condition |
---|
HIV Infection CMV Infection |
Study Type: | Observational |
Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Official Title: | Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals |
Resource links provided by NLM:
Further study details as provided by The Alfred:
![](https://webarchive.library.unt.edu/web/20130312224816im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Study Population
HIV infected patients with past CMV infection initiating antiretroviral therapy
Criteria
Inclusion Criteria:
- HIV positive with history of documented HCV infection
- Over 18 years old
- HIV positive
- Antiretroviral naive, starting on antiretroviral therapy
![](https://webarchive.library.unt.edu/web/20130312224816im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
![](https://webarchive.library.unt.edu/web/20130312224816im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
No publications provided
Responsible Party: | Jennifer Hoy, Professor Jennifer Hoy, The Alfred |
ClinicalTrials.gov Identifier: | NCT00168259 History of Changes |
Other Study ID Numbers: | 185/04 |
Study First Received: | September 13, 2005 |
Last Updated: | January 19, 2012 |
Health Authority: | Australia: National Health and Medical Research Council |
Keywords provided by The Alfred:
Treatment Naive HIV |
Additional relevant MeSH terms:
HIV Infections Acquired Immunodeficiency Syndrome Cytomegalovirus Infections HIV Seropositivity Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes |
Immune System Diseases Slow Virus Diseases Herpesviridae Infections DNA Virus Infections Interferon-gamma Interferons Antiviral Agents Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Antineoplastic Agents |
ClinicalTrials.gov processed this record on March 10, 2013